Brian Kennon
Overview
Explore the profile of Brian Kennon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
508
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sattar N, Kennon B, White A
Lancet Diabetes Endocrinol
. 2024 Aug;
12(10):687-690.
PMID: 39159642
No abstract available.
2.
McGurnaghan S, McKeigue P, Blackbourn L, Mellor J, Caparrotta T, Sattar N, et al.
Diabetes Care
. 2024 Jun;
47(8):1342-1349.
PMID: 38889071
Objective: In this study we examine whether hospitalized coronavirus disease 2019 (COVID-19) pneumonia increases long-term cardiovascular mortality more than other hospitalized pneumonias in people with type 2 diabetes and aim...
3.
Berthon W, McGurnaghan S, Blackbourn L, Mellor J, Gibb F, Heller S, et al.
Diabetes Res Clin Pract
. 2024 Mar;
210:111642.
PMID: 38548109
Aims: We examined severe hospitalised hypoglycaemia (SHH) rates in people with type 1 and type 2 diabetes in Scotland during 2016-2022, stratifying by sociodemographics. Methods: Using the Scottish National diabetes...
4.
Wang H, Cordiner R, Huang Y, Donnelly L, Hapca S, Collier A, et al.
Diabetes Care
. 2023 Mar;
46(5):967-977.
PMID: 36944118
Objective: To assess the real-world cardiovascular (CV) safety for sulfonylureas (SU), in comparison with dipeptidyl peptidase 4 inhibitors (DPP4i) and thiazolidinediones (TZD), through development of robust methodology for causal inference...
5.
Hohn A, McGurnaghan S, Caparrotta T, Jeyam A, OReilly J, Blackbourn L, et al.
PLoS One
. 2022 Aug;
17(8):e0271110.
PMID: 35951518
Background: We report the first study to estimate the socioeconomic gap in period life expectancy (LE) and life years spent with and without complications in a national cohort of individuals...
6.
Chamberlain R, Fleetwood K, Wild S, Colhoun H, Lindsay R, Petrie J, et al.
Diabetes Care
. 2021 Nov;
45(1):83-91.
PMID: 34782354
Objective: To describe incidence of foot ulceration and amputation-free survival associated with foot ulceration status in a national population-based cohort study of people with diabetes. Research Design And Methods: The...
7.
Captieux M, Fleetwood K, Kennon B, Sattar N, Lindsay R, Guthrie B, et al.
PLoS Med
. 2021 Nov;
18(11):e1003828.
PMID: 34727107
Background: Clinical pathways are changing to incorporate support and appropriate follow-up for people to achieve remission of type 2 diabetes, but there is limited understanding of the prevalence of remission...
8.
Jeyam A, Gibb F, McKnight J, OReilly J, Caparrotta T, Hohn A, et al.
Diabetologia
. 2021 Oct;
65(1):159-172.
PMID: 34618177
Aims/hypothesis: We assessed the real-world effect of flash monitor (FM) usage on HbA levels and diabetic ketoacidosis (DKA) and severe hospitalised hypoglycaemia (SHH) rates among people with type 1 diabetes...
9.
OReilly J, Jeyam A, Caparrotta T, Mellor J, Hohn A, McKeigue P, et al.
Diabetes Care
. 2021 Jul;
44(9):2010-2017.
PMID: 34244330
Objective: Whether advances in the management of type 1 diabetes are reducing rates of diabetic ketoacidosis (DKA) is unclear. We investigated time trends in DKA rates in a national cohort...
10.
Jeyam A, Gibb F, McKnight J, Kennon B, OReilly J, Caparrotta T, et al.
Diabetologia
. 2021 Mar;
64(6):1320-1331.
PMID: 33686483
Aims/hypothesis: Our aim was to assess the use of continuous subcutaneous insulin infusion (CSII) in people with type 1 diabetes in Scotland and its association with glycaemic control, as measured...